Data / Form D filings / Nexstim Plc
Nexstim Plc: Form D filing
Nexstim Plc, a biotechnology company in Helsinki, Finland, filed a Form D with the SEC in 2014. The latest, on December 22, 2014, reports $3.7 million sold of an offering with no set size to 1 investor.
Find out what Nexstim Plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Elimaenkatu 9B, Helsinki, Finland, FIN-0
- Phone
- 358 9 272 7170
- Industry
- Biotechnology
- Entity type
- Other (Public Limited Company)
- Incorporated in
- Finland
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1628859
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 22, 2014 | New notice | Indefinite | $3,748,304 | Indefinite | 1 | Nov 14, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Petriina Puolakka | Executive Officer | |
| Jarmo Laine | Executive Officer | |
| Olli Riikkala | Director | |
| Tim Irish | Director | |
| Casper Breum | Director | |
| John Hardin | Executive Officer | |
| Henri Hannula | Executive Officer | |
| Gustaf Jarnefelt | Executive Officer | |
| Katya ` Smirnyagina | Director | |
| Mikko Karvinen | Executive Officer | |
| Juha Vapaavuori | Director | |
| Rene Kuijten | Director | |
| Janne Huhtala | Executive Officer | |
| Johan Christenson | Director | |
| Ken ` Charhut | Director | |
| Rainer Harjunpaa | Executive Officer |
Every Form D from the week of Dec 22, 2014 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Nexstim Plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.